Chevy Chase Trust’s Regenxbio RGNX Stock Holding History

Chevy Chase Trust’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$41K	–	928
2019 Q4	$41K	Buy	+1,000	New	+$39.5K	﹤0.01%	864

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Chevy Chase Trust's RGNX Position: Q1 2020 in Review

Chevy Chase Trust sold out of Regenxbio (RGNX) in Q1 2020, closing a stake of 1,000 shares — an estimated $41K sold.

Chevy Chase Trust first reported a position in RGNX in Q4 2019 and held it in 1 quarter. The position peaked at $41K in Q4 2019. 170 funds tracked by Wall St. Rank hold RGNX as of Q1 2020.

Chevy Chase Trust reported no remaining Regenxbio position as of Q1 2020 after selling out during the quarter.
Chevy Chase Trust sold 1,000 Regenxbio shares in Q1 2020, an estimated $41K.
Chevy Chase Trust first reported a position in Regenxbio in Q4 2019 and held it in 1 quarter.
Chevy Chase Trust's Regenxbio position peaked at $41K in Q4 2019.
170 funds tracked by Wall St. Rank held Regenxbio as of Q1 2020.

Based on Chevy Chase Trust's 13F filing for Q1 2020, filed 13 May 2020.